Showing 4,221 - 4,240 results of 18,262 for search 'significantly ((((larger decrease) OR (((we decrease) OR (a decrease))))) OR (linear decrease))', query time: 0.55s Refine Results
  1. 4221

    Image2_RETRACTED: Effect of histone deacetylase inhibitors trichostatin A and valproic acid on hair cell regeneration in zebrafish lateral line neuromasts.JPEG by Yingzi He (12259307)

    Published 2024
    “…Additionally, BrdU immunostaining and western blot analysis showed that TSA or VPA treatment caused a significant decrease in the percentage of S-phase cells and induced p21<sup>Cip1</sup> and p27<sup>Kip1</sup> expression, both of which are likely to explain the decrease in the amount of newly regenerated hair cells in treated embryos. …”
  2. 4222

    Table1_RETRACTED: Effect of histone deacetylase inhibitors trichostatin A and valproic acid on hair cell regeneration in zebrafish lateral line neuromasts.PDF by Yingzi He (12259307)

    Published 2025
    “…Additionally, BrdU immunostaining and western blot analysis showed that TSA or VPA treatment caused a significant decrease in the percentage of S-phase cells and induced p21<sup>Cip1</sup> and p27<sup>Kip1</sup> expression, both of which are likely to explain the decrease in the amount of newly regenerated hair cells in treated embryos. …”
  3. 4223

    Image3_RETRACTED: Effect of histone deacetylase inhibitors trichostatin A and valproic acid on hair cell regeneration in zebrafish lateral line neuromasts.JPEG by Yingzi He (12259307)

    Published 2024
    “…Additionally, BrdU immunostaining and western blot analysis showed that TSA or VPA treatment caused a significant decrease in the percentage of S-phase cells and induced p21<sup>Cip1</sup> and p27<sup>Kip1</sup> expression, both of which are likely to explain the decrease in the amount of newly regenerated hair cells in treated embryos. …”
  4. 4224

    Table1_RETRACTED: Effect of histone deacetylase inhibitors trichostatin A and valproic acid on hair cell regeneration in zebrafish lateral line neuromasts.PDF by Yingzi He (12259307)

    Published 2024
    “…Additionally, BrdU immunostaining and western blot analysis showed that TSA or VPA treatment caused a significant decrease in the percentage of S-phase cells and induced p21<sup>Cip1</sup> and p27<sup>Kip1</sup> expression, both of which are likely to explain the decrease in the amount of newly regenerated hair cells in treated embryos. …”
  5. 4225

    Image3_RETRACTED: Effect of histone deacetylase inhibitors trichostatin A and valproic acid on hair cell regeneration in zebrafish lateral line neuromasts.JPEG by Yingzi He (12259307)

    Published 2025
    “…Additionally, BrdU immunostaining and western blot analysis showed that TSA or VPA treatment caused a significant decrease in the percentage of S-phase cells and induced p21<sup>Cip1</sup> and p27<sup>Kip1</sup> expression, both of which are likely to explain the decrease in the amount of newly regenerated hair cells in treated embryos. …”
  6. 4226

    Table1_RETRACTED: Effect of histone deacetylase inhibitors trichostatin A and valproic acid on hair cell regeneration in zebrafish lateral line neuromasts.PDF by Yingzi He (12259307)

    Published 2024
    “…Additionally, BrdU immunostaining and western blot analysis showed that TSA or VPA treatment caused a significant decrease in the percentage of S-phase cells and induced p21<sup>Cip1</sup> and p27<sup>Kip1</sup> expression, both of which are likely to explain the decrease in the amount of newly regenerated hair cells in treated embryos. …”
  7. 4227

    Table1_RETRACTED: Effect of histone deacetylase inhibitors trichostatin A and valproic acid on hair cell regeneration in zebrafish lateral line neuromasts.PDF by Yingzi He (12259307)

    Published 2024
    “…Additionally, BrdU immunostaining and western blot analysis showed that TSA or VPA treatment caused a significant decrease in the percentage of S-phase cells and induced p21<sup>Cip1</sup> and p27<sup>Kip1</sup> expression, both of which are likely to explain the decrease in the amount of newly regenerated hair cells in treated embryos. …”
  8. 4228

    Image1_RETRACTED: Effect of histone deacetylase inhibitors trichostatin A and valproic acid on hair cell regeneration in zebrafish lateral line neuromasts.JPEG by Yingzi He (12259307)

    Published 2024
    “…Additionally, BrdU immunostaining and western blot analysis showed that TSA or VPA treatment caused a significant decrease in the percentage of S-phase cells and induced p21<sup>Cip1</sup> and p27<sup>Kip1</sup> expression, both of which are likely to explain the decrease in the amount of newly regenerated hair cells in treated embryos. …”
  9. 4229

    Image1_RETRACTED: Effect of histone deacetylase inhibitors trichostatin A and valproic acid on hair cell regeneration in zebrafish lateral line neuromasts.JPEG by Yingzi He (12259307)

    Published 2024
    “…Additionally, BrdU immunostaining and western blot analysis showed that TSA or VPA treatment caused a significant decrease in the percentage of S-phase cells and induced p21<sup>Cip1</sup> and p27<sup>Kip1</sup> expression, both of which are likely to explain the decrease in the amount of newly regenerated hair cells in treated embryos. …”
  10. 4230

    Image2_RETRACTED: Effect of histone deacetylase inhibitors trichostatin A and valproic acid on hair cell regeneration in zebrafish lateral line neuromasts.JPEG by Yingzi He (12259307)

    Published 2024
    “…Additionally, BrdU immunostaining and western blot analysis showed that TSA or VPA treatment caused a significant decrease in the percentage of S-phase cells and induced p21<sup>Cip1</sup> and p27<sup>Kip1</sup> expression, both of which are likely to explain the decrease in the amount of newly regenerated hair cells in treated embryos. …”
  11. 4231

    Image2_RETRACTED: Effect of histone deacetylase inhibitors trichostatin A and valproic acid on hair cell regeneration in zebrafish lateral line neuromasts.JPEG by Yingzi He (12259307)

    Published 2025
    “…Additionally, BrdU immunostaining and western blot analysis showed that TSA or VPA treatment caused a significant decrease in the percentage of S-phase cells and induced p21<sup>Cip1</sup> and p27<sup>Kip1</sup> expression, both of which are likely to explain the decrease in the amount of newly regenerated hair cells in treated embryos. …”
  12. 4232

    Image2_RETRACTED: Effect of histone deacetylase inhibitors trichostatin A and valproic acid on hair cell regeneration in zebrafish lateral line neuromasts.JPEG by Yingzi He (12259307)

    Published 2024
    “…Additionally, BrdU immunostaining and western blot analysis showed that TSA or VPA treatment caused a significant decrease in the percentage of S-phase cells and induced p21<sup>Cip1</sup> and p27<sup>Kip1</sup> expression, both of which are likely to explain the decrease in the amount of newly regenerated hair cells in treated embryos. …”
  13. 4233

    Image1_RETRACTED: Effect of histone deacetylase inhibitors trichostatin A and valproic acid on hair cell regeneration in zebrafish lateral line neuromasts.JPEG by Yingzi He (12259307)

    Published 2025
    “…Additionally, BrdU immunostaining and western blot analysis showed that TSA or VPA treatment caused a significant decrease in the percentage of S-phase cells and induced p21<sup>Cip1</sup> and p27<sup>Kip1</sup> expression, both of which are likely to explain the decrease in the amount of newly regenerated hair cells in treated embryos. …”
  14. 4234

    Image3_RETRACTED: Effect of histone deacetylase inhibitors trichostatin A and valproic acid on hair cell regeneration in zebrafish lateral line neuromasts.JPEG by Yingzi He (12259307)

    Published 2024
    “…Additionally, BrdU immunostaining and western blot analysis showed that TSA or VPA treatment caused a significant decrease in the percentage of S-phase cells and induced p21<sup>Cip1</sup> and p27<sup>Kip1</sup> expression, both of which are likely to explain the decrease in the amount of newly regenerated hair cells in treated embryos. …”
  15. 4235
  16. 4236

    S1 Data - by Jessica C. M. Hui (20370522)

    Published 2024
    “…Compared to the SD, the HFD and SDG models exhibited significantly increased and decreased contraction velocities and could be used as models of diarrhoea and constipation in DM, respectively, while the ED model showed comparatively little change in motility. …”
  17. 4237

    Specifications of prototypes of RSSCA system. by Ngoc-Hai Vu (22290844)

    Published 2025
    “…Compared to conventional PV systems, the RSSCA offers improved light uniformity, better land-use efficiency, and significantly higher electricity generation. However, in regions with limited direct sunlight, such as Seoul in winter, system performance decreases. …”
  18. 4238

    Discovery of an Orally Active PDE1 Inhibitor for Disease-Modifying Treatment of Postmenopausal Osteoporosis via Dual Anabolic-Antiresorptive Mechanisms by Farman M. Abbasi (22318766)

    Published 2025
    “…In ovariectomized mice, <b>5cc</b> administration (5 mg/kg) improved the trabecular microarchitecture, bone mineral density, and strength, at levels comparable to teriparatide, while significantly reducing bone resorption markers. With 13.57% oral bioavailability and selectivity for PDE1A1 (32% inhibition at 500 nM), <b>5cc</b> offers an innovative therapeutic candidate for PMO with a dual anabolic-antiresorptive profile and oral efficacy, warranting further clinical development.…”
  19. 4239

    Discovery of an Orally Active PDE1 Inhibitor for Disease-Modifying Treatment of Postmenopausal Osteoporosis via Dual Anabolic-Antiresorptive Mechanisms by Farman M. Abbasi (22318766)

    Published 2025
    “…In ovariectomized mice, <b>5cc</b> administration (5 mg/kg) improved the trabecular microarchitecture, bone mineral density, and strength, at levels comparable to teriparatide, while significantly reducing bone resorption markers. With 13.57% oral bioavailability and selectivity for PDE1A1 (32% inhibition at 500 nM), <b>5cc</b> offers an innovative therapeutic candidate for PMO with a dual anabolic-antiresorptive profile and oral efficacy, warranting further clinical development.…”
  20. 4240

    Discovery of an Orally Active PDE1 Inhibitor for Disease-Modifying Treatment of Postmenopausal Osteoporosis via Dual Anabolic-Antiresorptive Mechanisms by Farman M. Abbasi (22318766)

    Published 2025
    “…In ovariectomized mice, <b>5cc</b> administration (5 mg/kg) improved the trabecular microarchitecture, bone mineral density, and strength, at levels comparable to teriparatide, while significantly reducing bone resorption markers. With 13.57% oral bioavailability and selectivity for PDE1A1 (32% inhibition at 500 nM), <b>5cc</b> offers an innovative therapeutic candidate for PMO with a dual anabolic-antiresorptive profile and oral efficacy, warranting further clinical development.…”